Interferon-induced anosmia in a patient with chronic hepatitis C

The American Journal of Gastroenterology
S MaruyamaM Nakamoto

Abstract

We report a patient with chronic active hepatitis C developing acute anosmia during interferon (IFN) therapy. On July 31, he began receiving 6 MU of IFN-alpha daily. On September 26, he failed to smell gas leaking from a gas cooker, so IFN therapy was discontinued. He showed no reaction on a standard olfactory acuity test. As the patient had borderline diabetes, the association of anosmia with impaired glucose tolerance cannot completely be excluded, but his anosmia was probably induced by IFN therapy, since anosmia developed 10 days after the initiation of the IFN therapy, without any deterioration of his glucose intolerance.

References

Jan 1, 1979·American Journal of Otolaryngology·R L Doty
Nov 1, 1989·Seminars in Liver Disease·P F Renault, J H Hoofnagle
Sep 1, 1984·The Journal of Clinical Investigation·C A DinarelloF Coceani
Nov 1, 1994·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V F Cocquyt, S J Van Belle
Sep 1, 1996·Journal of Hepatology·T OkanoueK Kashima

❮ Previous
Next ❯

Citations

Apr 29, 2006·Advances in Therapy·Atila MehmetGülhan M Haciyakupoglu
Mar 22, 2006·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Guido R Zanni
Oct 10, 2013·International Forum of Allergy & Rhinology·Tatyana Pozharskaya, Andrew P Lane
Dec 8, 2000·La Revue de médecine interne·J M NorèsP Bonfils

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

© 2021 Meta ULC. All rights reserved